Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life

Recruiting

Conditions: Retinoblastoma

Interventions: Behavioral: Questionnaires

First Posted Date: 2008-03-20

Last Posted Date: 2025-04-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1000

Registration Number: NCT00639301

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Procedure: Without ALLODERM, Questionnaires
Procedure: Alloderm, Questionnaires

First Posted Date: 2008-03-19

Last Posted Date: 2018-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 70

Registration Number: NCT00639106

Locations: 🇺🇸
University of Michigan Health System, Ann Arbor, Michigan, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States

Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Phase 2

Completed

Conditions: Acute Myeloid Leukemia
Advanced Myelodysplastic Syndromes

Interventions: Drug: Busulfan, Melphalan, Fludarabine, Anti-Thymocyte Globulin, Palifermin, Stem cell transplant

First Posted Date: 2008-03-06

Last Posted Date: 2021-09-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT00629798

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Sensory Morbidity Following Breast Surgery

Completed

Conditions: Breast Cancer

Interventions: Behavioral: questionnaires

First Posted Date: 2008-02-29

Last Posted Date: 2014-01-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 290

Registration Number: NCT00625924

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Expressive Writing and Adjustment to Metastatic Breast Cancer

Completed

Conditions: Metastatic Breast Cancer

Interventions: Behavioral: Writing Intervention

First Posted Date: 2008-02-26

Last Posted Date: 2015-10-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 98

Registration Number: NCT00624156

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation

Phase 1

Completed

Conditions: Leukemia
Myelodysplastic Syndrome

Interventions: Biological: WT1-sensitized T cells

First Posted Date: 2008-02-21

Last Posted Date: 2021-03-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT00620633

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma

Completed

Conditions: Head and Neck Squamous Cell Carcinoma

Interventions: Biological: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,

First Posted Date: 2008-02-21

Last Posted Date: 2013-10-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT00620139

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

Early Phase 1

Completed

Conditions: Ovarian Cancer

First Posted Date: 2008-02-21

Last Posted Date: 2012-01-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT00620243

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Not Applicable

Completed

Conditions: Breast Cancer
Adenocarcinoma of the Breast

Interventions: Drug: epirubicin, cyclophosphamide, Paclitaxel,

First Posted Date: 2008-02-18

Last Posted Date: 2015-12-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT00617370

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Drug: cyclophosphamide, methotrexate, fluorouracil, PEG-filgrastim

First Posted Date: 2008-02-14

Last Posted Date: 2017-03-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT00615901

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy